PHASE 2 TRIAL OF VORINOSTAT (SAHA) IN COMBINATION WITH GEMTUZUMAB OZOGAMICIN AS INDUCTION AND POST-REMISSION THERAPY IN OLDER PATIENTS WITH PREVIOUSLY UNTREATED ACUTE MYELOID LEUKEMIA (AML)

被引：0
|
作者：
Walter, B. [1 ]
Medeiros, B. [2 ]
Nielsen-Stoeck, M. [1 ]
Harrington, E. [1 ]
Powell, B. [3 ]
Schiffer, C. [4 ]
Appelbaum, F. [1 ]
Estey, E. [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Stanford Univ, Stanford, CA 94305 USA
[3] Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USA
[4] Wayne State Univ, Barbara Ann Karmanos Canc Ctr, Detroit, MI USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0073
引用
收藏
页码：29 / 30
页数：2
相关论文
共 50 条
  • [1] Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia
    Walter, Roland B.
    Medeiros, Bruno C.
    Powell, Bayard L.
    Schiffer, Charles A.
    Appelbaum, Frederick R.
    Estey, Elihu H.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (05): : 739 - 742
  • [2] Gemtuzumab Ozogamicin in Combination with Vorinostat and Azacitidine As Induction and Post-Remission Therapy in Older Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): A Phase 1 Study
    Walter, Roland B.
    Medeiros, Bruno C.
    Gardner, Kelda M.
    Estey, Elihu H.
    [J]. BLOOD, 2011, 118 (21) : 670 - 670
  • [3] Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia
    El Kinge, Abdul Rahman
    Hatourn, Hassan A.
    Mahfouz, Rami A.
    Otrock, Zaher K.
    Jabbour, Elias
    Kantarjian, Hagop
    Bazarbachi, Ali
    [J]. LEUKEMIA RESEARCH, 2009, 33 (04) : 565 - 566
  • [4] A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia
    Nand, Sucha
    Othus, Megan
    Godwin, John E.
    Willman, Cheryl L.
    Norwood, Thomas H.
    Howard, Dianna S.
    Coutre, Steven E.
    Erba, Harry P.
    Appelbaum, Frederick R.
    [J]. BLOOD, 2013, 122 (20) : 3432 - 3439
  • [5] The Value of Post-Remission Therapy in Older Adults with Acute Myeloid Leukemia (AML).
    Sekeres, Mikkael A.
    Fu, Alex Z.
    Earl, Marc
    Kalaycio, Matt
    Advani, Anjali
    Saunthararajah, Yogen
    Sobecks, Ronald
    Copelan, Edward
    [J]. BLOOD, 2009, 114 (22) : 431 - 432
  • [6] Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study
    Walter, Roland B.
    Medeiros, Bruno C.
    Gardner, Kelda M.
    Orlowski, Kaysey F.
    Gallegos, Leonel
    Scott, Bart L.
    Hendrie, Paul C.
    Estey, Elihu H.
    [J]. HAEMATOLOGICA, 2014, 99 (01) : 54 - 59
  • [7] Combination of datmorubicin and cytarabine chemotherapy with gemtuzumab ozogamicin as initial therapy for elderly patients with previously untreated acute myeloid leukemia.
    Kujawski, LA
    Ryan, I
    Griffith, K
    Erba, HP
    [J]. BLOOD, 2005, 106 (11) : 238B - 238B
  • [8] Race and Intensity of Post-Remission Therapy in Acute Myeloid Leukemia (AML).
    Brady, Anna K.
    Fu, Alex Z.
    Earl, Marc
    Kalaycio, Matt
    Advani, Anjali
    Saunthararajah, Yogen
    Sobecks, Ronald
    Copelan, Edward
    Sekeres, Mikkael A.
    [J]. BLOOD, 2009, 114 (22) : 419 - 419
  • [9] Gemtuzumab ozogamicin (Mylotarg®) as primary induction therapy for elderly patients with acute myeloid leukemia:: A phase II trial
    Kujawski, LA
    Gartner, EM
    Ryan, I
    Griffith, K
    Erba, HP
    [J]. BLOOD, 2004, 104 (11) : 210B - 210B
  • [10] A Phase II Trial of Azacitidine (NSC-102816) and Gemtuzumab Ozogamicin (NSC-720568) As Induction and Post-Remission Therapy in Patients of Age 60 and Older with Previously Untreated Non-M3 Acute Myeloid Leukemia (SWOG S0703): Report On the Poor Risk Patients
    Nand, Sucha
    Othus, Megan
    Godwin, John E.
    Willman, Cheryl L.
    Norwood, Thomas
    Erba, Harry Paul
    Howard, Dianna
    Coutre, Steven E.
    Appelbaum, Frederick R.
    [J]. BLOOD, 2012, 120 (21)
12345